Fenster schließen  |  Fenster drucken

[posting]59861995[/posting]doch doch... BTIG!

Geron Jumps as BTIG Starts Coverage at Buy Ahead of Catalysts
By Bailey Lipschultz

(Bloomberg) -- Geron rose 15% pre-market after BTIG analyst Thomas Shrader
initiated coverage with a buy rating ahead of 2019 catalysts. Fellow microcaps
Synlogic and MEI Pharma were also rated new buys.
GERN (PT $4)’s imetelstat has shown promise in MDS and
myelofibrosis in early-stage studies ahead of potential pivotal trials
likely starting this year, Shrader wrote
Cash positioning should get the company “well into the
Imetelstat Phase 3 program”
 
aus der Diskussion: Geron mit Hammernews!!
Autor (Datum des Eintrages): Sugar2000  (13.02.19 14:16:57)
Beitrag: 3,019 von 3,060 (ID:59862685)
Alle Angaben ohne Gewähr © wallstreet:online